Journal Article

DKFZ-2018-01823

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

von Hagens, C. ; Walter-Sack, I. ; Goeckenjan, M. ; Storch-Hagenlocher, B. ; Sertel, S. ; Elsässer, M. ; Remppis, B. A. ; Munzinger, J. ; Edler, L.DKFZ* ; Efferth, T.DKFZ* ; Schneeweiss, A. ; Strowitzki, T.

2019
Elsevier München [u.a.]

Please use a persistent id in citations: doi:10.1016/j.phymed.2018.09.178

---

Contributing Institute(s):

1. Biostatistik (C060)
2. Pharmazeutische Biologie von Naturstoffen (C015)

Research Program(s):

1. 313 - Cancer risk factors and prevention (POF3-313) (POF3-313)

Appears in the scientific report 2019

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---